Finance

Lists
GANX:NASDAQ
Gain Therapeutics Inc
1,71 $
-0,58%
(-0,0100) 1D
1,75 $
+2,34% (+0,040)
Pre-market
Closed: 2 հոկ, 16:00:01 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for GANX...
Open
1,75 $
High
1,78 $
Low
1,70 $
Mkt. cap
74,63 մլն
Avg. vol.
418,76 հզր
Volume
0,00
52-wk high
4,34 $
52-wk low
1,53 $
EPS
-0,51 $
Beta
0,19
Shares outstanding
43,64 մլն
No. of employees
21
Open
1,75 $
High
1,78 $
Low
1,70 $
Mkt. cap
74,63 մլն
Avg. vol.
418,76 հզր
Volume
0,00
52-wk high
4,34 $
52-wk low
1,53 $
EPS
-0,51 $
Beta
0,19
Shares outstanding
43,64 մլն
No. of employees
21
News stories
From web sources and news partners
About Gain Therapeutics Inc
CEO-
Employees21
Founded2017
Headquarters-
Sector-
Websitegaintherapeutics.com
Analyst ratings
Based on 5 analysts giving stock ratings to GANX in the past 3 months
Strong buy
Buy
5
Hold
0
Sell
0
12-month forecast
Based on 5 Wall Street analysts offering 12 month price targets for GANX in the last 3 months.
Highest
Current 1,71 $
8,00 $ (+367,84%)
Average
7,20 $ (+321,05%)
Lowest
5,00 $ (+192,40%)
Analyst
Recommendation
Action
Price target
Projected
Date
Jason McCarthy
Maxim Group
Buy
Maintained
7,00 $
+309,4%
10/01/2026
Ram Selvaraju
H.C. Wainwright
Buy
Reiterated
8,00 $
+367,8%
08/31/2026
Boobalan Pachaiyappan
Roth MKM
Buy
Maintained
8,00 $
+367,8%
08/18/2026
Unknown Analyst
Oppenheimer
Buy
Maintained
8,00 $
+367,8%
08/13/2026
Thomas Shrader
BTIG
Buy
Maintained
5,00 $
+192,4%
08/11/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025 թ. սեպ
2025 թ. դեկ
2026 թ. մրտ
2026 թ. հնս
Revenue
-
-
-
-
Cost of goods sold
2,81 մլն
2,32 մլն
2,74 մլն
2,12 մլն
Cost of revenue
2,81 մլն
2,32 մլն
2,74 մլն
2,12 մլն
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1,98 մլն
2,15 մլն
2,61 մլն
2,56 մլն
Operating expense
1,98 մլն
2,15 մլն
2,61 մլն
2,56 մլն
Total operating expenses
4,79 մլն
4,47 մլն
5,35 մլն
4,68 մլն
Operating income
-4,79 մլն
-4,47 մլն
-5,35 մլն
-4,68 մլն
Other non operating income
-
-
-
-
EBT including unusual items
-4,74 մլն
-4,47 մլն
-5,43 մլն
-4,57 մլն
EBT excluding unusual items
-4,74 մլն
-4,47 մլն
-5,43 մլն
-4,57 մլն
Income tax expense
549,29 հզր
70,12 հզր
183,07 հզր
104,07 հզր
Effective tax rate
-11,60%
-1,57%
-3,37%
-2,28%
Other operating expenses
-
-
-
-
Net income
-5,28 մլն
-4,54 մլն
-5,61 մլն
-4,68 մլն
Net profit margin
-
-
-
-
Earnings per share
-0,15
-0,11
-0,13
-0,11
Interest and investment income
83,30 հզր
88,58 հզր
93,34 հզր
60,73 հզր
Interest expense
-
-
-
-
Net interest expenses
83,30 հզր
88,58 հզր
93,34 հզր
60,73 հզր
Depreciation and amortization charges
-
-
-
-
EBITDA
-4,78 մլն
-4,46 մլն
-5,34 մլն
-4,67 մլն
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google Apps